{"id":61047,"date":"2020-06-04T16:08:06","date_gmt":"2020-06-04T14:08:06","guid":{"rendered":"https:\/\/cms.munich-startup.net\/?p=61047"},"modified":"2022-02-28T13:50:36","modified_gmt":"2022-02-28T12:50:36","slug":"irubis-receives-13-million-euros-from-eu-project","status":"publish","type":"post","link":"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/","title":{"rendered":"Irubis receives 1.3 million euros from EU project"},"content":{"rendered":"
\n

The Munich-based biotech startup Irubis has received 1.3 million euros in funding under the EU's Horizon 2020 funding program. The European Innovation Council (EIC) single-project aims to develop a novel measurement system for the automated monitoring and control of manufacturing processes in the biopharmaceutical industry.<\/strong><\/p>\n\n\n\n

Irubis is known for its novel sample carrier for ATR infrared spectroscopy<\/a>This technology has been used in laboratory analysis for many years to analyze a wide variety of materials and substances. The Irubis sample carrier significantly reduces costs while ensuring better results.<\/p>\n\n\n\n

Irubis develops measuring device for drug production<\/h2>\n\n\n\n

The Munich-based company is also developing a new measuring device that can be used to monitor and regulate the production of biopharmaceutical drugs. This process control enables higher yields, improved quality, and shortens the overall process development time. <\/p>\n\n\n\n

With financial support from Horizon 2020, Irubis will bring this innovative process monitoring technology to market readiness. It is an optical measuring device based on infrared spectroscopy that can be used to continuously monitor and control nutrient concentrations in bioreactors. With the fresh capital from the EU program, the ten-person team will be further expanded and extensive test runs and collaborations with customers from the biopharmaceutical industry will be realized.<\/p>\n\n\n\n

 "The biopharmaceutical industry faces the major challenge of developing a vaccine against SARS-CoV-2 within a very short time and producing it in large quantities. This particularly highlights how important it is that biopharmaceuticals can be developed more quickly and cost-effectively so that they are available to patients. We are providing an important building block for this,"<\/p><\/blockquote>\n\n\n\n

explains co-founder and CTO Lorenz Sykora<\/strong>. And further:<\/p>\n\n\n\n

"Through our close collaboration with industry, we work in a very customer-focused manner. Our goal is to offer a holistic solution for process monitoring and control."<\/p><\/blockquote>\n<\/div>","protected":false},"excerpt":{"rendered":"

The Munich-based biotech startup Irubis has received \u20ac1.3 million in funding as part of the EU's Horizon 2020 funding program. The European Innovation Council (EIC) single-project project aims to develop a novel measurement system for the automated monitoring and control of manufacturing processes in the biopharmaceutical industry. Irubis is known for its innovative sample carrier for ATR infrared spectroscopy. The\u2026<\/p>","protected":false},"author":33,"featured_media":61049,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[5633,1],"tags":[371,505,3985,52,2935],"acf":[],"yoast_head":"\nIrubis erh\u00e4lt 1,3 Millionen Euro aus EU-Projekt - Munich Startup<\/title>\n<meta name=\"description\" content=\"Das M\u00fcnchner Startup Irubis etwickelt ein Messger\u00e4t, mit dem die Herstellung von Medikamenten \u00fcberwacht und reguliert werden kann.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Irubis erh\u00e4lt 1,3 Millionen Euro aus EU-Projekt - Munich Startup\" \/>\n<meta property=\"og:description\" content=\"Das M\u00fcnchner Startup Irubis etwickelt ein Messger\u00e4t, mit dem die Herstellung von Medikamenten \u00fcberwacht und reguliert werden kann.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/\" \/>\n<meta property=\"og:site_name\" content=\"Munich Startup\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/munichstartup\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-04T14:08:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-02-28T12:50:36+00:00\" \/>\n<meta name=\"author\" content=\"Maximilian Feigl\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:site\" content=\"@munich_startup\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maximilian Feigl\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/\",\"name\":\"Irubis erh\u00e4lt 1,3 Millionen Euro aus EU-Projekt - Munich Startup\",\"isPartOf\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/06\/rsz_184241.jpg\",\"datePublished\":\"2020-06-04T14:08:06+00:00\",\"dateModified\":\"2022-02-28T12:50:36+00:00\",\"author\":{\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\"},\"description\":\"Das M\u00fcnchner Startup Irubis etwickelt ein Messger\u00e4t, mit dem die Herstellung von Medikamenten \u00fcberwacht und reguliert werden kann.\",\"breadcrumb\":{\"@id\":\"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/#primaryimage\",\"url\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/06\/rsz_184241.jpg\",\"contentUrl\":\"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/06\/rsz_184241.jpg\",\"width\":2400,\"height\":1602,\"caption\":\"Irubis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cms.munich-startup.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Irubis erh\u00e4lt 1,3 Millionen Euro aus EU-Projekt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cms.munich-startup.net\/#website\",\"url\":\"https:\/\/cms.munich-startup.net\/\",\"name\":\"Munich Startup\",\"description\":\"Das offizielle Startup-Portal f\u00fcr M\u00fcnchen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cms.munich-startup.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509\",\"name\":\"Maximilian Feigl\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g\",\"caption\":\"Maximilian Feigl\"},\"description\":\"Maximilian Feigl berichtet seit 2020 \u00fcber das M\u00fcnchner Startup \u00d6kosystem. Dabei haben es dem studierten Politikwissenschaftler vor allem Deeptech-Themen angetan.\",\"url\":\"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/\"}]}<\/script>\n<meta property=\"og:image\" content=\"https:\/\/cms.munich-startup.net\/en\/wp-content\/uploads\/2020\/06\/rsz_184241.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2400\" \/>\n\t<meta property=\"og:image:height\" content=\"1602\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Irubis receives 1.3 million euros from EU project - Munich Startup","description":"The Munich-based startup Irubis is developing a measuring device that can be used to monitor and regulate the production of medicines.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/","og_locale":"en_US","og_type":"article","og_title":"Irubis erh\u00e4lt 1,3 Millionen Euro aus EU-Projekt - Munich Startup","og_description":"Das M\u00fcnchner Startup Irubis etwickelt ein Messger\u00e4t, mit dem die Herstellung von Medikamenten \u00fcberwacht und reguliert werden kann.","og_url":"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/","og_site_name":"Munich Startup","article_publisher":"https:\/\/www.facebook.com\/munichstartup\/","article_published_time":"2020-06-04T14:08:06+00:00","article_modified_time":"2022-02-28T12:50:36+00:00","author":"Maximilian Feigl","twitter_card":"summary_large_image","twitter_creator":"@munich_startup","twitter_site":"@munich_startup","twitter_misc":{"Written by":"Maximilian Feigl","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/","url":"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/","name":"Irubis receives 1.3 million euros from EU project - Munich Startup","isPartOf":{"@id":"https:\/\/cms.munich-startup.net\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/#primaryimage"},"image":{"@id":"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/#primaryimage"},"thumbnailUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/06\/rsz_184241.jpg","datePublished":"2020-06-04T14:08:06+00:00","dateModified":"2022-02-28T12:50:36+00:00","author":{"@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509"},"description":"The Munich-based startup Irubis is developing a measuring device that can be used to monitor and regulate the production of medicines.","breadcrumb":{"@id":"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/#primaryimage","url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/06\/rsz_184241.jpg","contentUrl":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/06\/rsz_184241.jpg","width":2400,"height":1602,"caption":"Irubis"},{"@type":"BreadcrumbList","@id":"https:\/\/cms.munich-startup.net\/en\/61047\/irubis-receives-13-million-euros-from-eu-project\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cms.munich-startup.net\/"},{"@type":"ListItem","position":2,"name":"Irubis erh\u00e4lt 1,3 Millionen Euro aus EU-Projekt"}]},{"@type":"WebSite","@id":"https:\/\/cms.munich-startup.net\/#website","url":"https:\/\/cms.munich-startup.net\/","name":"Munich Startup","description":"The official startup portal for Munich","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cms.munich-startup.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/40ec2127e0b2a722f0cb734a53f43509","name":"Maximilian Feigl","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cms.munich-startup.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/194fab98a3d18da0d43ab2b73b348908?s=96&d=blank&r=g","caption":"Maximilian Feigl"},"description":"Maximilian Feigl has been reporting on the Munich startup ecosystem since 2020. The political scientist is particularly interested in deeptech topics.","url":"https:\/\/cms.munich-startup.net\/en\/author\/feigl\/"}]},"og_image":[{"width":2400,"height":1602,"url":"https:\/\/cms.munich-startup.net\/wp-content\/uploads\/2020\/06\/rsz_184241.jpg","type":"image\/jpeg"}]},"_showyear":"","_inactive":"","_show_financing":"","_hide_on_map":"","_edit_lock":"1649834563:38","_edit_last":"38","_yoast_wpseo_focuskw":"Irubis","_yoast_wpseo_metadesc":"Das M\u00fcnchner Startup Irubis etwickelt ein Messger\u00e4t, mit dem die Herstellung von Medikamenten \u00fcberwacht und reguliert werden kann.","_yoast_wpseo_linkdex":"71","_thumbnail_id":"61049","wbounce_status":"default","_yoast_wpseo_primary_category":"5633","_yoast_wpseo_focuskw_text_input":"","_yoast_wpseo_content_score":"30","ms_image_format":"contentwidth","_ms_image_format":"field_5cb8587572c8b","ms_dachzeile":"","_ms_dachzeile":"field_5cd9b7f365df5","ms_bump_post_date":"","_ms_bump_post_date":"field_5d1341edcf42a","guest_author_name":"","_guest_author_name":"field_5cee78a6016f9","guest_author_image":"","_guest_author_image":"field_5cee7914016fb","guest_author_description":"","_guest_author_description":"field_5cee78dd016fa","ms_post_image_caption":"","_ms_post_image_caption":"field_5f735b0735284","ms_post_image_credit":"","_ms_post_image_credit":"field_5f735b1435285","suppress_startupbox":"0","_suppress_startupbox":"field_60a64b0b6efc6","_yoast_wpseo_estimated-reading-time-minutes":"2","_wp_old_date":"","_yoast_wpseo_title":"","_yoast_wpseo_wordproof_timestamp":"","footnotes":"","easy_language_simplification_original_id":"","easy_language_source_language":"","easy_language_simplification_language":"","easy_language_api":"","easy_language_prevent_automatic_mode":"","_wp_old_slug":"","_wp_trash_meta_status":"","_wp_trash_meta_time":"","easy_language_simplification_state_changed_from":"","easy_language_de_EL_changed":"","ms_competition_deadline":"","_ms_competition_deadline":"","_wpbitly":"","enclosure":"","_yoast_wpseo_meta-robots-noindex":"","_yoast_wpseo_meta-robots-nofollow":"","wbounce_template":"","wbounce_title":"","wbounce_text":"","wbounce_cta":"","wbounce_url":"","wbounce_override":"","_yoast_wpseo_opengraph-title":"","_yoast_wpseo_opengraph-description":"","_oembed_7131efca3705e16bd9da2c41df237660":"","_oembed_time_7131efca3705e16bd9da2c41df237660":"","_pprredirect_type":"","_pprredirect_url":"","_yoast_wpseo_opengraph-image":"","_yoast_wpseo_opengraph-image-id":"","_newsletterglue":"","easy_language_text_language":"","_wp_desired_post_slug":"","_relevanssi_noindex_reason":"","_links":{"self":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/61047"}],"collection":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/comments?post=61047"}],"version-history":[{"count":4,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/61047\/revisions"}],"predecessor-version":[{"id":80331,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/posts\/61047\/revisions\/80331"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media\/61049"}],"wp:attachment":[{"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/media?parent=61047"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/categories?post=61047"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cms.munich-startup.net\/en\/wp-json\/wp\/v2\/tags?post=61047"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}